XML 27 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-Based Compensation (Tables)
3 Months Ended
Jul. 30, 2016
Stock-Based Compensation [Abstract]  
Stock-based compensation expense by type
The compensation costs that have been charged against income for the thirteen and twenty-six weeks ended July 30, 2016 and August 1, 2015 were as follows (in thousands):

  
Thirteen Weeks Ended
  
Twenty-Six Weeks Ended
 
  
July 30, 2016
  
August 1, 2015
  
July 30, 2016
  
August 1, 2015
 
Stock-based compensation expense by type:
            
Stock options
 
$
3
  
$
18
  
$
384
  
$
359
 
Restricted stock unit awards, including performance-based
  
898
   
887
   
2,607
   
3,165
 
Employee stock purchases
  
22
   
21
   
58
   
58
 
Director deferred compensation
  
24
   
18
   
47
   
35
 
Total stock-based compensation expense
  
947
   
944
   
3,096
   
3,617
 
Income tax benefit recognized
  
344
   
346
   
1,125
   
1,331
 
Stock-based compensation expense, net of income tax
 
$
603
  
$
598
  
$
1,971
  
$
2,286
 
Equity awards granted during the period
In the thirteen and twenty-six weeks ended July 30, 2016 and August 1, 2015, we granted the following equity awards:

  
Thirteen Weeks Ended
  
Twenty-Six Weeks Ended
 
  
July 30, 2016
  
August 1, 2015
  
July 30, 2016
  
August 1, 2015
 
Stock options
  
318
   
1,138
   
36,359
   
20,228
 
Restricted stock unit awards
  
-
   
-
   
100,775
   
69,529
 
Performance-based restricted stock unit awards
  
-
   
-
   
45,300
   
29,300
 
Deferred stock units
  
674
   
376
   
14,156
   
11,628
 
Employee Stock Purchases during the period
Our employee purchases of common stock, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follow:

  
Thirteen Weeks Ended
  
Twenty-Six Weeks Ended
 
  
July 30, 2016
  
August 1, 2015
  
July 30, 2016
  
August 1, 2015
 
Shares purchased
  
3,021
   
2,042
   
8,638
   
5,491
 
Average price per share
 
$
29.57
  
$
39.59
  
$
27.05
  
$
40.58
 
Weighted average fair value at grant date
 
$
7.49
  
$
10.23
  
$
6.83
  
$
10.54